FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Related Tags >> Nabi Biopharmaceuticals   Vaccine   FDA
Syndicate content

NicVAX News

Most Popular NicVAX Story

Nabi explores options after NicVAX flunks trial

Nabi Biopharmaceuticals ($NABI) was hit hard earlier this week after the company's smoking cessation vaccine NicVAX flunked a second late-stage trial. Data showed the primary endpoint was not met in Read more...

NicVAX Press Releases

  • Nabi Biopharmaceuticals Announces Successful Final Results of NicVAX(r) Immunogenicity Study
  • PRESS RELEASE: Nabi Biopharmaceuticals Announces Successful Completion of NicVAX Phase 2b Trial
  • PRESS RELEASE: Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months

Latest Headlines